Exacerbation of Darier disease by peg‐interferon beta‐1a in a patient suffering from multiple sclerosis

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-4632|57|1|116-117

ISSN： 0011-9059

Source： INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol.57, Iss.1, 2018-01, pp. : 116-117

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Interferon beta‐1b‐induced Sweet's syndrome in a patient with multiple sclerosis

By  

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 54, Iss. 4, 2015-04 ,pp. : 456-458

John Wiley & Sons Inc

Access to resources Recommend Favorite

Levofloxacin-Induced Delirium in a Patient Suffering from Schizoaffective Disorder and Multiple Sclerosis

By  

Current Drug Safety, Vol. 8, Iss. 3, 2013-07 ,pp. : 199-200

Bentham Science Publishers

Access to resources Recommend Favorite

PK and PD of peginterferon beta‐1a in multiple sclerosis patients

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 79, Iss. 3, 2015-03 ,pp. : 514-522

John Wiley & Sons Inc

Access to resources Recommend Favorite

Glatiramer acetate versus interferon Beta-1a for subcutaneous administration: Comparison of outcomes among multiple sclerosis patients

By Castelli-Haley Jane  

Advances in Therapy, Vol. 25, Iss. 8, 2008-08 ,pp. : 830-830

Springer Publishing Company

Access to resources Recommend Favorite

Development of systemic sarcoidosis and xanthoma planum during multiple sclerosis treatment with interferon‐beta 1a: Case Report

By  

INTERNATIONAL JOURNAL OF DERMATOLOGY, Vol. 54, Iss. 5, 2015-05 ,pp. : e140-e145

John Wiley & Sons Inc

Access to resources Recommend Favorite